Download PDF
Zeitschrift für Komplementärmedizin 2021; 13(02): 20-25
DOI: 10.1055/a-1410-1522
Wissen
Ernährungstherapie

Fettleber – das große Potenzial von Ernährungs- und Fastentherapie

Andreas Michalsen∗
› Further Information
    Permissions and Reprints

Summary

Die Fettlebererkrankung ist eine Volkskrankheit geworden und auch prognostisch von Bedeutung. Durch Heilfasten und modifizierte Formen periodischen Fastens können schnelle Verbesserungen und Remissionen erzielt werden. Entscheidend ist präventiv wie kurativ aber die grundsätzliche Ernährung.

Keywords

Leber - Fettleber - Ernährung - Fasten - NAFLD - nichtalkoholische Fettlebererkrankung


Publication History

Article published online:
21 April 2021

© 2021. Thieme. All rights reserved.

© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co.
KG

 

  • Literatur

  • 1 Koopman KE. et al Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial. Hepatology 2014; 60 (02) 545-553
    CrossrefPubMedGoogle Scholar
  • 2 Kahleova H. et al Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: A randomised crossover study. Diabetologia 2014; 57 (08) 1552-1560
    CrossrefPubMedGoogle Scholar
  • 3 Fuhrmeister J. et al Fasting-induced liver GADD45β restrains hepatic fatty acid uptake and improves metabolic health. EMBO Mol Med 2016; 8 (06) 654-669
    CrossrefPubMedGoogle Scholar
  • 4 Quiclet C. et al Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice. Metabolism 2019; 97: 9-17
    CrossrefPubMedGoogle Scholar
  • 5 Wilhelmi de Toledo F. et al Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One 2019; 14 (01) e0209353
    CrossrefPubMedGoogle Scholar
  • 6 Drinda S. et al Effects of periodic fasting on fatty liver index – A prospective observational study. Nutrients 2019; 11 (11) 2601
    CrossrefPubMedGoogle Scholar
  • 7 Li C. et al Effects of a one-week fasting therapy in patients with type-2 diabetes mellitus and metabolic syndrome – A randomized controlled explorative study. Exp Clin Endocrinol Diabetes 2017; 125 (09) 618-624
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Stange R. et al Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance. Forsch Komplementmed 2013; 20 (06) 421-426
    CrossrefPubMedGoogle Scholar
  • 9 Xu C. et al High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels. Liver Int 2020; 40 (12) 2982-2997
    CrossrefPubMedGoogle Scholar
  • 10 Brandhorst S, Longo VD.. Protein quantity and source, fasting-mimicking diets, and longevity. Adv Nutr 2019; 10 (Suppl. 04) S340-S350
    CrossrefPubMedGoogle Scholar
  • 11 Le Couteur DG. et al Dietary protein, ageing and the Okinawan ratio. Age Ageing 2016; 45 (04) 443-447
    CrossrefPubMedGoogle Scholar
  • 12 Ascher S, Reinhardt C. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease. Eur J Immunol 2018; 48 (04) 564-575
    CrossrefPubMedGoogle Scholar
  • 13 Kahleova H. et al Effect of a low-fat vegan diet on body weight, insulin sensitivity, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults: A randomized clinical trial. JAMA Netw Open 2020; 3 (11) e2025454
    CrossrefPubMedGoogle Scholar
  • 14 Simons N. et al Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial. Am J Clin Nutr 2021; 113 (02) 391-400
    CrossrefPubMedGoogle Scholar